Literature DB >> 7754749

Dysembryoplastic neuroepithelial tumor: report of a case without typical glioneuronal elements.

K Iwanaga1, H Takahashi, S Kameyama, R Tanaka, F Ikuta.   

Abstract

We studied a temporal lobe lesion found in a 44-year-old woman with a 25-year history of intractable complex partial seizures. Histologically, the lesion contained several nodular areas differing in cellular composition within the disarranged uncal cortex; in each area, neuronal and small round cells, mature ganglion cells and fibrillary astrocytic cells predominated. Ultrastructurally, the small round cells demonstrated neuronal, astrocytic or oligodendrocytic features. The astrocytic cell processes were occasionally covered by basal laminae. The mature ganglion cells had well-developed rough endoplasmic reticulum, many mitochondria and lipofuscin granules in their cytoplasm. No dense-cored vesicles were evident. We diagnosed this temporal lobe lesion as a dysembryoplastic neuroepithelial tumor (DNT), although no areas of typical glioneuronal elements with mucinous matrix were evident. This case suggests that a glioneuronal element is not always a constant feature of DNT, and that although mature ganglion cell nodules may be present, they may differ from those of gangliocytomas and gangliogliomas in lacking intracytoplasmic dense-cored vesicles. The presence of occasional astrocytic cell processes covered by basal laminae strongly suggests that some of the constituent astrocytic cells were of subpial astrocytic origin.

Entities:  

Mesh:

Year:  1995        PMID: 7754749     DOI: 10.1007/BF00309345

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  15 in total

1.  Esthesioneuroblastoma: a nasal catecholamine-producing tumor of neural crest origin. Demonstration of tyrosine hydroxylase-immunoreactive tumor cells.

Authors:  H Takahashi; K Wakabayashi; F Ikuta; K Tanimura
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

2.  Temporal lobe tumor demonstrating ganglioglioma and pleomorphic xanthoastrocytoma components. Case report.

Authors:  A Furuta; H Takahashi; F Ikuta; K Onda; N Takeda; R Tanaka
Journal:  J Neurosurg       Date:  1992-07       Impact factor: 5.115

3.  Immunocytochemical localization of synaptic vesicle-specific protein in Lewy body-containing neurons in Parkinson's disease.

Authors:  K Wakabayashi; H Takahashi; K Obata; F Ikuta
Journal:  Neurosci Lett       Date:  1992-04-27       Impact factor: 3.046

Review 4.  Dysembryoplastic neuroepithelial tumours.

Authors:  C Daumas-Duport
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

5.  Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases.

Authors:  J J Kepes; L J Rubinstein; L F Eng
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860

6.  Dysembryoplastic neuroepithelial tumor. A tumor with small neuronal cells resembling oligodendroglioma.

Authors:  S Y Leung; E Gwi; H K Ng; C F Fung; K Y Yam
Journal:  Am J Surg Pathol       Date:  1994-06       Impact factor: 6.394

7.  [Dysembryoplastic neuroepithelial tumor; a case report].

Authors:  H Hasegawa; S Bitoh; K Koshino; J Obashi; Y Kobayashi
Journal:  No Shinkei Geka       Date:  1991-06

8.  Dysembryoplastic neuroeptihelial tumor (DNT): an immunohistochemical and ultrastructural study.

Authors:  T Hirose; B W Scheithauer; M B Lopes; S R VandenBerg
Journal:  J Neuropathol Exp Neurol       Date:  1994-03       Impact factor: 3.685

9.  Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases.

Authors:  C Daumas-Duport; B W Scheithauer; J P Chodkiewicz; E R Laws; C Vedrenne
Journal:  Neurosurgery       Date:  1988-11       Impact factor: 4.654

10.  Neuroblastoma and the differential diagnosis of small-, round-, blue-cell tumors.

Authors:  T J Triche; F B Askin
Journal:  Hum Pathol       Date:  1983-07       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.